Got to take a long term view with these biotechs - SRX valuation by Hunter Hall and Huntleys is closer to $30 if certain sales targets are met .
AAH
arana therapeutics limited
there last attempt at an australian company, page-3
Add to My Watchlist
What is My Watchlist?